-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GRWD-5769 in Cervical Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. GRWD-5769 in Cervical Cancer Drug Details: GRWD-5769 is under development for the treatment of solid...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – RT-403 in Liver Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.RT-403 in Liver CancerDrug Details:RT-403 is under development for the treatment of liver cancer, lung cancer...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – AD-109 in Snoring
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.AD-109 in SnoringDrug Details:AD-109 is under development for the treatment of obstructive sleep apnea and snoring....
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Acute Myocardial Infarction in Myocardial Infarction
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Acute Myocardial Infarction in Myocardial Infarction Drug Details: Biologic is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – LHP-588 in Periodontal Disease
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.LHP-588 in Periodontal DiseaseDrug Details:LHP-588 is under development for the treatment of mild to moderate dementia,...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – EG-501 in Systemic Lupus Erythematosus
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.EG-501 in Systemic Lupus Erythematosus Drug Details:EG-501 is under development for the treatment of cognitive impairment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – SAR-444419 in Inflammation
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.SAR-444419 in InflammationDrug Details: SAR444419 is under development for the treatment of inflammation. It acts by...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Allopurinol +Verinurad) in Chronic Kidney Disease (Chronic Renal Failure)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.(Allopurinol +Verinurad) in Chronic Kidney Disease (Chronic Renal Failure)Drug Details:A fixed-dose combination of allopurinol and verinurad...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – APBR-3 in Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.APBR-3 in Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease)Drug Details:APBR-3 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – DKY-709 in Metastatic Colorectal Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. DKY-709 in Metastatic Colorectal Cancer Drug Details: DKY-709 is under development for the treatment of...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.